106 related articles for article (PubMed ID: 19241604)
1. Expression of VEGF, iNOS, and eNOS is increased in cochlea of diabetic rat.
Liu F; Xia M; Xu A
Acta Otolaryngol; 2008 Nov; 128(11):1178-86. PubMed ID: 19241604
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Cukiernik M; Hileeto D; Evans T; Mukherjee S; Downey D; Chakrabarti S
Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity.
Kaur C; Sivakumar V; Ang LS; Sundaresan A
J Neurochem; 2006 Aug; 98(4):1200-16. PubMed ID: 16787408
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
[TBL] [Abstract][Full Text] [Related]
5. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats.
Takeda M; Mori F; Yoshida A; Takamiya A; Nakagomi S; Sato E; Kiyama H
Diabetologia; 2001 Aug; 44(8):1043-50. PubMed ID: 11484083
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F
Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386
[TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi N; Mowa CN; Maeda S; Hattori Y; Miyauchi T
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754
[TBL] [Abstract][Full Text] [Related]
11. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
Bojunga J; Dresar-Mayert B; Usadel KH; Kusterer K; Zeuzem S
Biochem Biophys Res Commun; 2004 Apr; 316(3):771-80. PubMed ID: 15033467
[TBL] [Abstract][Full Text] [Related]
12. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis.
Inamori M; Shimamura T; Nagase H; Abe Y; Umezawa T; Nakajima A; Saito T; Ueno N; Tanaka K; Sekihara H; Togawa J; Kaifu H; Tsuboi H; Kayama H; Tominaga S
Hepatogastroenterology; 2006; 53(69):361-5. PubMed ID: 16795973
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats.
Nakamaki S; Satoh H; Kudoh A; Hayashi Y; Hirai H; Watanabe T
Exp Biol Med (Maywood); 2011 May; 236(5):614-20. PubMed ID: 21521713
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts.
Felaco M; Grilli A; De Lutiis MA; Patruno A; Libertini N; Taccardi AA; Di Napoli P; Di Giulio C; Barbacane R; Conti P
Ann Clin Lab Sci; 2001 Apr; 31(2):179-86. PubMed ID: 11337908
[TBL] [Abstract][Full Text] [Related]
16. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
Malyshev E; Tazi KA; Moreau R; Lebrec D
J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
[TBL] [Abstract][Full Text] [Related]
17. Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide?
Rhee CK
Laryngoscope; 2003 Dec; 113(12):2059-66. PubMed ID: 14660903
[TBL] [Abstract][Full Text] [Related]
18. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.
Komers R; Schutzer WE; Reed JF; Lindsley JN; Oyama TT; Buck DC; Mader SL; Anderson S
Diabetes; 2006 Jun; 55(6):1651-9. PubMed ID: 16731827
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthases II and III and vascular endothelial growth factor are up-regulated in sciatic nerve after spiral cuff electrode implantation.
Thil MA; Vince V; Veraart C; Delbeke J; Colin IM
J Neuroimmunol; 2005 Sep; 166(1-2):158-66. PubMed ID: 16038988
[TBL] [Abstract][Full Text] [Related]
20. Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity.
Yang JW; Han ST; Kim YS; Song SH; Kim BR; Eom MS; Jung SH; Choi SO; Han BG
Transplant Proc; 2010 Dec; 42(10):4625-32. PubMed ID: 21168749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
